Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Female Fertility And Pregnancy Rapid Test Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The female fertility and pregnancy rapid test market size has demonstrated significant growth in recent years. It is anticipated to expand from $1.48 billion in 2025 to $1.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. The historical growth in this market can be attributed to factors such as increasing awareness of female reproductive health, a rise in the use of ovulation predictor kits, expanding retail availability of rapid tests, the growth of hospital-based diagnostic testing, and an increasing incidence of infertility diagnoses._x000D_
_x000D_
The female fertility and pregnancy rapid test market is anticipated to show significant expansion over the upcoming years. It will grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. This projected growth stems from several factors, including an escalating need for early pregnancy detection, the increasing integration of digital health monitoring solutions, a heightened emphasis on personalized fertility management, the broadening scope of telehealth-supported diagnostics, and the deeper market penetration of e-commerce healthcare products. Furthermore, significant trends for the forecast period involve a greater acceptance of at-home rapid testing kits, a surging requirement for digital and app-connected test devices, the expanding application of combo fertility and pregnancy tests, the widening of online distribution networks, and an intensified focus on creating user-friendly and precise test designs._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Female Fertility And Pregnancy Rapid Test Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The rising incidence of gynecological disorders is projected to boost the expansion of the female fertility and pregnancy rapid test market in the coming years. Gynecological issues are medical conditions affecting female reproductive organs, specifically the breasts, as well as abdominal and pelvic structures such as the womb (uterus), ovaries, vagina, fallopian tubes, and vulva. These rapid tests for female fertility and pregnancy assist with gynecological disorders by enabling early detection of hormonal imbalances or pregnancy-related problems, thereby supporting timely diagnosis and effective management of reproductive health conditions. For example, a report released in May 2025 by the National Library of Medicine, a US-based government organization, stated that approximately 61.2% of women experienced at least one gynecological morbidity, with dysmenorrhea being the most common (61.3%), followed by irregular menses (36.1%) and infertility (36.1%). Therefore, the increasing occurrence of gynecological disorders is propelling the growth of the female fertility and pregnancy rapid test market._x000D_
_x000D_
#Female Fertility And Pregnancy Rapid Test Market Segmentation And Category Overview#_x000D_
The female fertility and pregnancy rapid test market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Fertility Rapid Test Kits, Pregnancy Rapid Test Kits_x000D_
2) By Device Type: Digital Devices, Line-indicator Devices_x000D_
3) By Test Type: FSH Urine Test, LH Urine Test, hCG Blood Test, hCG Urine Test_x000D_
4) By Distribution Channel: Hospital Channel, Retail Channel, Online Channel _x000D_
_x000D_
Subsegments:_x000D_
1) By Fertility Rapid Test Kits: Ovulation Predictor Kits, Luteinizing Hormone (LH) Test Kits, Follicle-Stimulating Hormone (FSH) Test Kits _x000D_
2) By Pregnancy Rapid Test Kits: Urine-Based Pregnancy Tests, Blood-Based Pregnancy Tests, Combo Fertility And Pregnancy Tests _x000D_
_x000D_
#Female Fertility And Pregnancy Rapid Test Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Major companies operating in the female fertility and pregnancy rapid test market are focusing on developing innovative solutions, such as saliva-based home pregnancy tests, to meet the rising demand for non-invasive methods. A saliva-based pregnancy test is a lateral-flow, point-of-care assay designed to detect pregnancy biomarkers in oral fluid instead of urine. For Instance, in May 2024, Abingdon Health plc, a UK-based lateral flow CDMO, launched the world’s first Boots-branded saliva pregnancy self-test, making this saliva-based technology available in mainstream retail through Boots stores and online. The product features a saliva collection interface and a proprietary lateral-flow immunoassay, developed with Salignostics and Crest Medical, crafted to bind and indicate the presence of the pregnancy biomarker in oral fluid. It functions as a rapid, single-use self-test that gives a result within minutes and is packaged for OTC sale. It uniquely removes urine collection from the testing workflow, thereby improving comfort and hygiene, supports consumer adoption through a familiar “stick/cassette” format, and is intended for routine home screening and early confirmation of pregnancy, leveraging the added retail reach and consumer trust of Boots._x000D_
_x000D_
#Female Fertility And Pregnancy Rapid Test Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the female fertility and pregnancy rapid test market are Abbott Laboratories, Atlas Medical GmbH, bioMérieux SA, Church & Dwight Co. Inc., Quidel Corporation, Egens Group, Eurofins Scientific SE, Everlywell Inc., Genea Pty Limited, Geratherm Medical AG, SA Scientific Ltd., Artron Laboratories Inc., PRIMA Lab SA, The Procter & Gamble Company, Alere Inc., Prestige Brands Holdings Inc., SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Fertility Focus Limited, HiLin Life Products Inc., Inverness Medical Innovations Inc., UEBE Medical GmbH, Wondfo Biotech Co. Ltd. _x000D_
_x000D_
#View The Full Female Fertility And Pregnancy Rapid Test Market Report:#_x000D_
_x000D_
#Female Fertility And Pregnancy Rapid Test Market Regional Outlook: Where Is Opportunity Concentrated?#_x000D_
North America was the largest region in the female fertility and pregnancy rapid test market in 2025. The regions covered in the female fertility and pregnancy rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
